NHLBI Warfarin Trial to Use Trimgen Tests | GenomeWeb

NEW YORK (GenomeWeb News) — The National Heart Lung and Blood Institute will use TrimGen's eQ-PCR Warfarin Genotyping Kit in a clinical trial designed to find out if a gene-based strategy will benefit patients who are at high risk for warfarin sensitivity.

Sensitivity to the blood-thinning drug can result in a higher risk of thromboembolism and bleeding, and can lead doctors to discontinue the therapy early.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.